This study indicates that demographic factors influence the inter-individual variability in the disposition of the combination drug , and it might be more useful to apply it to the PK of olmesartan medoxomil/hydrochlorothiazide ( 20/12 .5 mg ) FDC tablets administered to patients with hypertension .